As of 2025-12-18, the Relative Valuation of Pharmala Biotech Holdings Inc (MDMA.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 CAD, the upside of Pharmala Biotech Holdings Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-12-12 | -4.46 |
| 2025-12-11 | -4.67 |
| 2025-12-10 | -4.67 |
| 2025-12-09 | -3.85 |
| 2025-12-08 | -3.65 |
| 2025-12-05 | -3.65 |
| 2025-12-04 | -3.65 |
| 2025-12-03 | -3.65 |
| 2025-12-02 | -3.65 |
| 2025-12-01 | -3.85 |
| 2025-11-28 | -4.06 |
| 2025-11-27 | -4.26 |
| 2025-11-26 | -4.06 |
| 2025-11-25 | -4.26 |
| 2025-11-24 | -4.06 |
| 2025-11-21 | -4.46 |
| 2025-11-20 | -4.67 |
| 2025-11-19 | -4.46 |
| 2025-11-18 | -4.67 |
| 2025-11-17 | -4.67 |
| 2025-11-14 | -4.87 |
| 2025-11-13 | -4.87 |
| 2025-11-12 | -4.46 |
| 2025-11-11 | -4.26 |
| 2025-11-10 | -4.46 |
| 2025-11-07 | -4.67 |
| 2025-11-06 | -5.07 |
| 2025-11-05 | -5.07 |
| 2025-11-04 | -4.67 |
| 2025-11-03 | -4.87 |
| 2025-10-31 | -5.07 |
| 2025-10-30 | -4.46 |
| 2025-10-29 | -5.27 |
| 2025-10-28 | -5.68 |
| 2025-10-27 | -4.46 |
| 2025-10-24 | -4.26 |
| 2025-10-23 | -4.06 |
| 2025-10-22 | -4.46 |
| 2025-10-21 | -4.46 |
| 2025-10-20 | -4.26 |
| 2025-10-17 | -4.46 |
| 2025-10-16 | -4.46 |
| 2025-10-15 | -4.46 |
| 2025-10-14 | -4.46 |
| 2025-10-10 | -4.67 |
| 2025-10-09 | -4.87 |
| 2025-10-08 | -4.87 |
| 2025-10-07 | -4.67 |
| 2025-10-06 | -4.67 |
| 2025-10-03 | -4.87 |